SCIENTIFIC PROGRAM

2 December 2021, Thursday COURSES-ONLINE PROGRAM

HALL 1
08:20 – 09:10

Nursing Care in Gastrointestinal Cancers
Moderators:
Duygu Hicdurmaz, Zafer Arik, Kaya Yorganci, Suayib Yalcin

08:20-08:30

  • The Pivotal Role of the Nurse in Management of GI Cancers - Ozlem Er

08:30-08:40

  • Surgery Related Symptom Control in Gastrointestinal Tumors - Gulbeyaz Can

08:40-08:50

  • Chemotherapy Related Symptom Management in Gastrointestinal Tumors - Ezgi Bahcevan

08:50-09:00

  • Wound and Stoma Care after Gastrointestinal Tumor Surgery - Deniz Harputlu

09:00-09:10

  • Psychosocial Care during the Gastrointestinal Cancers Course - Sinem Uzar Ozcetin
09:10 - 09:20 Break
09:20 – 10:20

Rare Gastrointestinal Tumors Course
Chair: Orhan Turken

09:20 - 09:35   

  • Gastric Lymhomas - Ismail Erturk

09:35 – 09:50     

  • Hemangioendotelyoma - Umut Kefeli

09:50 - 10:05    

  • Small Intestinal Cancer - Yesim Yildirim

10:05 - 10:20    

  • Appendix Mucinous Neoplasia - Yasemin Kemal
10:20 - 10:30 Break
10:30 – 12:00

Special Issues in the Management of Gastrointestinal Cancers
Chairs:
Turkkan Evrensel, Nuriye Ozdemir Yildirim, Tarkan Yetisyigit

10:30-10:40

  • Managing Chemotherapy Induced Neutropenia Gastrointestinal Cancers - Elvina Almuradova

10:40-10:55

  • Practical Approach to Drug Allergies in GI Oncology - Burak Yasin Aktas, Ebru Damadoglu

10:55- 11:15

  • Principles of Nutrional Support in Gastrointestinal Cancer Patients - Meltem Halil

11:15- 11:30

  • Management of Chemotherapy Associated Hepatotoxicity - Ali Alkan

11:30- 11:45

  • How Safe is Immunotherapy, How can We Recognise and Treat Immune-Related Toxicity - Leyla Ozer

11:45- 12:00

  • Addressing Cardiac Toxicity in GI Cancer Patient - Sernaz Uzunoglu
12:00 - 12:10 Break
12:10 – 12:40

Covid Pandemia and  Gastrointestinal Oncology
Chairs:
Ahmet Demirkazık, Ahmet Ozet

12:10-12:25

  • Adult Vaccination in Patients with GI Cancers During Covid Era - Ebru Cilbir

12:25-12:40

  • Covid Vaccination in Cancer Patients - Murat Akova
12:40 – 13:40 LUNCH
13:40 – 15:00

CRC Pathophysiology and Genetics of Colorectal Cancers
Chairs: Timucin Cil, John Souglakos, Berna Oksuzoglu, Demetris Papamichael

13:40-14:00

  • Obesity and Colorectal Carcinogenesis - Mehmet Artac

14:00-14:20

  • NLR and Inflammation Colon Cancer - Mehmet Ali Nahit Sendur

14:20-14:40

  • Vitamin D and Colon Cancer - Ofer Purim

14:40-15:00

  • Hereditary Basis of Colon Cancer - Omer Dizdar
15:00 - 15:15 Break
15:15 – 16:00

Genekor Satellite Symposium
Precision Medicine in Oncology Practice:

Comprehensive Molecular Profiling
Chair: Suayib Yalcin

Speaker: Umut Demirci

16:00 - 16:15 Break
16:15 - 17:15

Supportive Care in GI Cancers Course
Chairs: Taflan Salepci, Gokhan Celenkoglu

16:15-16:30

  • Nause and Vomitting - Nilufer Bulut

16:30-16:45

  • Pain Management - Altan Sahin

16:45-17:00

  • Thrombocytopenia Causes and Management  - Serkan Akın

17:00-17:15

  • Principles of Intensive Care in Gastrointestinal Oncology - Kaya Yorganci
17:15 - 17:30

Break

17:30 – 19:15

Role Radiology and Nuclear Medicine in the Management of Gastrointestinal Cancer Course
Moderators: Okan Akhan, Murat Fani Bozkurt

17:30-17:45

  • Principles of Radiological Imaging in Gastrointestinal Oncology - Ivana Blazic

17:45-18:00

  • Cross Sectional Imaging of Abdomen - Ali Devrim Karaosmanoglu

18:00-18:15

  • Cross Sectional Imaging of Thorax - Gamze Durhan

18:15-18:30

  • Principles of Radiological Ablative Treatments - Devrim Akinci

18:30-18:45

  • Principles of Embolization Treatments in GI Cancers - Bora Peynircioglu

18:45-19:00

  • Nuclear Imaging in Gastrointestinal Cancers - Murat Fani Bozkurt

19:00-19:15

  • Essentials of Radionuclide Treatment for GI Cancers - Bilge Volkan Salanci
19:15 - 19:30 Break
19:30 – 20:30

Tumor Board Multidisiplinary Approach to a Biliary Tract Cancer
Moderator: Gokhan Demir

19:30-19:45

  • Radiology: Mustafa Parildar

19:45-20:00

  • Pathology: Arzu Avci

20:00-20:15

  • Surgery: Unal Aydin 

20:15-20:30

  • Medical Oncology: Ibrahim Petekkaya
HALL 2
08:30 – 10:00

Epidemiology of Gastrointestinal Cancers Course
Moderators:
Berksoy Sahin, Berna Oksuzoglu

08:30-08:40

  • Esophageal Cancers: Dilsa Mizrak Kaya

08:40-08:50

  • Gastric Cancers: Anthony Lopez

08:50-09:00

  • Small Bowel Cancer: Onur Esbah Ilyasoglu

09:00-09:10

  • Colon Cancer: Tolga Koseci 

09:10-09:20

  • Anal Cancer: Ayse Demirci

09:20-09:30

  • Pancreatic Cancer: Irem Bilgetekin

09:30-09:40

  • Biliary Cancer: Ahmet Siyar Ekinci

09:40-09:50

  • Hepatocellular Cancer: Ertugrul Bayram

09:50-10:00

  • Pediatric Cancer: Tezer Kutluk
10:00 - 10:15 Break
10:15 – 11:55

Principles of Surgery in Gastrointestinal Oncology Course
Moderator:
Kaya Yorganci

10:15-10:25

  • Introduction: Kaya Yorganci

10:25-10:35

  • Esophageal Tumors: Sebahattin Celik

10:35-10:45

  • Gastric Tumors: Nezih Akkapulu

10:45-10:55

  • Colon Tumors: Arman Erkan

10:55-11:05

  • Rectum Tumors: Timucin Erol

11:05-11:15

  • Liver Tumors: Ahmet Bulent Dogrul

11:15-11:25

  • Biliary&Gall Bladder Tumors: Tufan Egeli 

11:25-11:35

  • Pancreatic Tumors: Anil Dincer

11:35-11:45

  • NET: Omer Cennet

11:45-11:55

  • GIST: Taylan Sezer
11:55 - 13:30 LUNCH
13:30 – 15:15

Pathology Course: Outlines of Gastrointestinal and Hepatopancreatobiliary Malignant Tumors
Moderators:
Sibel Erdamar, Cenk Sokmensuer

13:30-13:45

  • Pathology of Esophagial Carcinomas - Deniz Tuncel

13:45-14:00

  • Pathology of Gastric Carcinomas - Nevra Dursun

14:00-14:15

  • Pathology of Colorectal Carcinomas - Meral Uner

14:15-14:30

  • Pathology of Malignant Tumors of Liver - Burcu Saka

14:30-14:45

  • Pathology of Pancreatic Carcinomas - Pelin Bagci

14:45-15:00

  • Pathology of GEPNET - Orhun Cig Taskin

15:00-15:15

  • Pathology of GIST - Damlanur Sakiz
15:15 - 15:25 Break
15:25 – 17:15

Immunotherapy in Gastrointestinal Cancers Course
Moderators: Ozgur Tanriverdi, Suayib Yalcin

15:25-15:35

  • Introduction: Ozgur Tanriverdi

15:35-15:45

  • Immunological Basis of Carcinogenesis in Gastrointestinal Tumors: Aysegul Yildiz

15:45-15:55

  • Markers for Immunotherapy: Ozlem Yersal

15:55-16:05

  • PD-1 Inhibitors: Serkan Degirmencioglu

16:05-16:15

  • PD-L1 Inhibitors: Esin Oktay

16:15-16:25

  • CTLA4 Inhibitors: Cigdem Usul Afsar

16:25-16:35

  • CAR-T Cell Therapies: Ali Alkan

16:35-16:45

  • Cancer Vaccines: Hacer Demir

16:45-16:55

  • Combination of Radiotherapy with Immunotherapy: Gorkem Turkkan

16:55-17:05

  • Adverse Events: Ozan Yazici

17:05-17:15

  • Current Clinical Practice and Future Directions: Ozgur Tanriverdi
17:15 - 17:25 Break
17:25 – 18:15

Endoscopical Interventions and Imaging Courses Role of Endoscopy in Gastrointestinal Oncology
Moderator: Halis Simsek

17:25-17:35

  • Endoscopic Screening for Colorectal Cancer - Mehmet Cindoruk

17:35-17:45

Role of EUS in Gastrointestinal Lesions - Mehmet Bektas

17:45-17:55

  • Stenting for Esophageal, Gastroduodenal and Colorectal Cancers - Murat Kekilli

17:55-18:05

  • ERCP and EUS for Hepatopancreaticobiliary Cancers - Filiz Akyuz

18:05-18:15

  • Imaging Small Bowel: Capsule Endoscopy and Enteroscopy - Cengiz Pata
18:15 - 18:30 Break
18:30 - 19:20

Screening in Gastrointestinal Oncology Course
Moderator:
Saadettin Kilickap

18:30-18:40

  • CRC Cancer Screening Programs in Turkey and the World - Ece Esin

18:40-18:50

  • Endoscopy, Radiology and Fecal Tests for CRC Screening - Burak Yasin Aktas

18:50-19:00

  • Molecular Tests in Genetic/Familial Tumors - Ozan Yazici

19:00-19:10

  • Diagnosis and Treatment of Barret Esophagus - Cem Simsek

19:10-19:20

  • Conclusion - Saadettin Kilickap
19:20 - 19:30 Break
19:30 - 21:20

Video Festival: Reporting from the Clinics
Moderators: Suayib Yalcin, Zafer Arik, Neyran Kertmen, Serkan Akin

19:30-19:40

  • Hipomagnesemia - Oktay Aktepe

19:40-19:50

  • BRCA Mutant Pancreatic Cancer - Cagri Yildirim

19:50-20:00

  • Oxaliplatin Induced Thrombocytopenia - Gurkan Guner 

20:00-20:10

  • Sinusoidal Obtruction Syndrome - Hakan Taban 

20:10-20:20

  • Watch Out for Drug Interactions - Canan Karan

20:20-20:30

  • Anticoagulant Treatment in Advanced Pancreatic Cancer - Seda Kahraman

20:30-20:40

  • Pulmonary Toxicity in GI Cancers: What can We do  - Feride Yılmaz

20:40-20:50

  • Systemic Management of Bone Metastasis in GI Cancers - Serkan Yasar

20:50-21:00

  • Bone Marrow Involvement and Gastrointestinal Cancers - Nilay Sengul

21:00-21:10

  • Integrating Quality of Life Measures into the Daily Clinical Practice in GI Oncology - Cihan Erol

21:10-21:20

  • Management of Drug Extravasation During Chemotherapy - Turkan Ozturk Topcu

3 December 2021, Friday

08:30 – 09:50

Session I: Opening Session Impact of Precision Medicine in Colon Cancer
Chairs
: Suayib Yalcin, Philip Agop Philip, Ilias Athanasiadis

08:30-08:50

  • Tumor Heterogeneity as a Multi-headed Dragon: A Moving Target Challenging Precision Medicine - Dan Aderka 

08:50-09:10

  • Role of Immunoscore in Colon and Rectal Cancer - Ofer Purim

09:10-09:30

  • Role of ctDNA in MRD Detection, Relapse Monitoring and Treatment Response Monitoring in Colon Cancer - Suayib Yalcin

09:30-09:50

  • Marker Driven Treatment for Metastatic Colon Cancer - Axel Grothey
09:50 - 10:45

Session II: Esophageal Cancer Management: How should I Treat in 2021
Chairs:
David Ilson, Bulent Tirnaksiz, Faruk Zorlu, Sinan Ersin

09:50-10:10

  • Esophageal Cancer Management: How should I Treat in 2021 - Jamal Khader

10:10-10:25

  • Emerging Systemic Treatment Options for Esophageal Cancer - Dilsa Mizrak Kaya

10:25-10:40

  • Perioperative Chemotherapy or Neoadjuvant Chemadiotherapy for Esophageal Cancers - Huseyin Engin

10:40-10:45 Discussion: Oktay Aktepe, Hakan Taban

10:45 - 11:00 Coffee Break
11:00 - 11:45 Lilly Satellite Symposium
Ramucirumab in Metastatic Gastric Cancer Treatment
Speakers:
Umut Demirci, Nuri Karadurmus
11:45 - 13:00

Session III: Gastric Cancer: towards more Individualized Approach
Chairs: Mahmut Gumus, Esra Kaytan Saglam, Ender Kurt

11:45-12:05

  • Adjuvant/Neoadjuvant Therapy in Gastric Cancer - Gokhan Demir

12:05-12:25

  • Role of Radiotherapy as Adjuvant and Neoadjuvant Treatment - Pervin Hurmuz 

12:25-12:45

  • Advances in the Systemic Treatment of Advanced Gastric Cancer - David Ilson

12:45-13:00

  • Management of HER-2 Positive Gastric Cancer - Suayib Yalcin
13:00 - 13:45 LUNCH
13:45 - 14:30 BMS Satellite Symposium
Nivolumab Experience in MSI-H or dMMR Metastatic Colorectal Cancer
Chair:
Nuri Faruk Aykan
Speaker:
Mehmet Ali Nahit Sendur
14:30 - 15:45

Session IV: Pancreatic Cancer
Chairs: Fuat Demirelli, Basak Oyan Uluc, Tugba Yavuzsen

14:30-14:50

  • Adjuvant/Neoadjuvant Treatment in Resectable Pancreas Cancer? - Marwan Ghosn

14:50- 15:05

  • Increasing Role of Genetics and Molecular Alterations in the Management of Pancreatic Cancer - Ozcan Yildiz

15:05- 15:20

  • MR Linac for Pancreatic and Other GI Cancers - Enis Ozyar

15:20-15:45

  • Advances in the Systemic Treatment of Pancreatic Cancer - Philip Agop Philip 
15:45 - 16:30

Session V: Hepatocellular Tumors
Chairs: Halis Simsek, Erkan Dogan, Neyran Kertmen

15:45-15:55

  • New Perspectives in Classification of HCC - Sahin Lacin 

15:55-16:15

  • Advances in the Systemic Treatment of Hepatocellular Cancer - Ahmed Kaseb

16:15-16:25

  • Pediatric Liver Tumors - Tezer Kutluk

16:25-16:30 Discussion: Feride Yilmaz, Serkan Yasar

16:30 - 17:15 Gen Satellite Symposium
Lanreotide Treatment in GEP-NET
Chair:
Bulent Orhan
Speaker:
Suayib Yalcin
17:15 - 17:30 Coffee Break
17:30 - 18:30

Session VI: Biliary Tract Cancer
Chairs:
Necdet Uskent, Ioannis Boukovinas, Ahmed Kaseb

17:30-18:10  Moleculer Pathways in Biliary Tract Cancers What Have We Learnt so Far
17:30-17:50

  • From Molecular Patologist Perspective - Sibel Erdamar

17:50-18:10

  • From Clinical Perspective - Reham Abdelwahab

18:10-18:30

  • Systemic Treatment for Biliary  Tract Cancer - Shouki Bazarbashi
18:30 - 19:10

Session VII: Update On GIST Tumors
Chairs: Tamer Elkiran, Ozlem Er

18:30-18:50

  • Understanding the Molecular Biology of GISTs - Tulay Akman

18:50-19:10

  • Update on GIST Management - Ioannis Boukovinas
19:10 - 19:40

Session VIII: Management of NETs
Chairs:
Biljana Grozdanovska Angelovska, Philip Agop Philip

19:10-19:35

  • Systemic Treatment in Advanced GEPNETS - Ramon Salazar

19:35-19:40 Discussion: Ezgi Degerli

19:40 - 20:40 Amgen Satellite Symposium
Optimal Systemic Treatment Strategies with Case Discussions in mCRC
Moderator: Suayib Yalcin
Speaker & Discusser: Ramon Salazar
Case Presentation: Cigdem Usul Afsar

 

 

4 December 2021, Saturday

08:10 – 08:50

Session IX: Anal Cancer
Chairs:
Ilhan Oztop, Durmus Etiz,

08:10-08:30

  • Advances is the Multimodality Treatment for Localized Disease - Ferah Yildiz

08:30-08:50

  • New Systemic Treatment Options for Metastatic Disease - Ece Esin
08:50 - 09:50

Session X: Localized Rectal Cancer
Chairs:
Philip Agop Philip, Alper Sevinc, Zafer Arik

08:50-09:10

  • Individualizing Adjuvant/ Neoadjuvant Treatment for Rectal Cancer - Ugur Selek

09:10-09:30

  • Surgical Management of Rectal Cancer: Current Approach Future Directions - Oktar Asoglu

09:30-09:50

  • Total Neoadjuvant Treatment and non Operative Management: Time for Paradigm Shift? - Claus Henning Kohne
09:50 - 10:10 Coffee Break
10:10 - 11:10

Session XI: Update on Colon Cancer Summary of the Year
Chairs:
Idris Yucel, Nuran Senel Bese,Bulent Karabulut

10:10-10:30

  • Update on Adjuvant Therapy in Colon Cancer - John Souglakos

10:30-10:50

  • Update on the First-Line Treatment in mCRCDirk Arnold

10:50-11:10

  • Update on the Salvage in mCRC - Meral Günaldı
11:10 - 11:55 Amgen Satellite Symposium
Importance of Treatment Sequencing in RAS WT mCRC 1st line Patients and Position of Panitumumab
Chair:
Faysal Dane
Speaker:
Ozlem Sonmez
11:55 - 12:55

Session XII: Implications of Age and Gender in the Management of Colon Cancer
Chairs:
Handan Onur, Erdem Goker, Aziz Karaoglu

11:55-12:15

  • Elderly Patients with Colon Cancers - Demetris Papamichael

12:15-12:35

  • Young Patients with Colon Cancers - Ilias Athanasiadis

12:35-12:55

  • Gender Differences in Colon Cancers - Marc Peeters
12:55 - 13:40 LUNCH
13:40 - 14:15

Session XIII: a Closer Look on Individualized Treatment in Advanced Colon Cancer
Chairs:
Ali Arican, Ahmet Şiyar Ekinci

13:40-13:55

  • NTRK Rearrangements in Metastatic Colorectal Cancer - Ebru Cilbir

13:55-14:15

  • Clinical Implications of HER-2 Positivity in Metastatic Colon Cancer - Ibrahim Halil Sahin
14:15 - 14:45

Session XIV: Newer Tissue Agnostics Pathways to asTraetment Targets in GI Cancers
Chairs:
Jesus Garcia Foncillas, Halil Kavgaci

14:15-14:30

  • Targeting FGFR Alterations in GI Cancers - Gamze Gokoz Dogu

14:30-14:45

  • Understanding RET Alterations as Treatment Targets in GI Cancers - Bulent Orhan
14:45 - 15:30 Bayer Satellite Symposium
HCC Diagnosis and Beyond
Chair:
Suayib Yalcin
HCC Diagnosis with Primovist
- Sukru Mehmet Erturk
Systemic Treatment with Nexavar and Stivarga
- Sahin Lacin
15:30 - 15:50 Coffee Break
15:50-16:35 Abbott Satellite Symposium
Nutrition from the Medical Oncologist Perspective
How can We Improve the Outcome of Cancer Treatment through Medical Nutrition
Chair:
Suayib Yalcin
Speakers:
Suayib Yalcin, Ozlem Er
16:35-16:55 Session XV: IL 7 in MSS CRC and PDAC
Chair:
Murat Dincer
Speaker:
Aung Naing
16:55 - 18:00

Session XVI: Optimizing CRC Treatment in Advanced Stage
Chairs:
Isil Somali, Evin Buyukunal, Coskun Tecimer

16:55-17:15

  • Assessing MMR/MSI in Colorectal Cancer: Management of Discrepancies - Sibel Erdamar

17:15-17:35

  • Role of Maintenance Therapy in Advanced CRC - Ali Shamseddine

17:35-17:55

  • Treatment Beyond Second Line: Choosing Patients - Cagatay Arslan
18:00 – 18:45

Session XVII: Advanced RAS Mutant Colorectal Cancer
Chairs: Hakan Akbulut, Faruk Aykan

18:00-18:20

  • Clinical Characteristics of RAS Mutant Colorectal Cancers - Anes Pasic

18:20-18:40

  • Optimal Systemic Treatment Strategies for Ras Mutant Colorectal Cancer - Marc Peeters
18:45 – 19:50

Session XVIII: Cytoreductive Surgery and HIPEC
Chairs:
 Cem Terzi, Bulent Orhan, Musa Akoglu

18:45-19:05

  • Improving the Outcome: does the Cytotoxic Regimen with Hypertermia Used after SRS Matter? - Deniz Can Guven 

19:05-19:25

  • Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery for Gastrointestinal Cancers - Ali Ekrem Unal 

19:25-19:45

  • Why are the Results of Clinical Studies with HİPEC are Disappointing - Fatih Kose

19:45-19:50 Discussion: Ozturk Ates

 

 

5 December 2021, Sunday

08:30 – 09:30

Session XIX: We can Better Understand and Treat Metastatic Colorectal Cancer
Chairs:Ofer Purim, Halil Kavgaci, Ulus Ali Sanli

08:30 - 08:50    

  • Right Versus Left Colon - Mutlu Dogan

08:50 – 09:10   

  • Addressing BRAF Mutant mCRC - Ozkan Kanat

09:10 - 09:30   

  • Controversies on First Line Chemotherapy Regimens - Jesus Garcia Foncillas
09:30 – 10:00

Session XX: Debate
Chairs: Erdem Goker, Berksoy Sahin

09:30 - 09:45

  • Irinotecan Based Chemo for First Line is Better - Ozan Yazici

09:45 - 10:00

  • Oxaliplatin Based Chemo for First Line is Better - Arzu Oguz
10:00 - 11:10

Session XXI: Changing Paradigm in Colorectal Cancer
Chairs: Hande Turna, John Souglakos,Bulent Karabulut

10:00 - 10:15

  • Are We there: Neoadjuvant Treatment for Colon Cancer - Ozlem Yersal

10:15 - 10:35

  • Understanding the Importance of Tumor Microenvironment in CRC - Dan Aderka

10:35 - 10:55

  • Genomic/Signature Tools for Prediction of Risk in Early Stage Colon Cancer - Jesus Garcia Foncillas

10:55 - 11:10

  • Systemic Therapy for MSI High Colon Cancer - Huseyin Abali
11:10 - 11:35 Coffee Break
11:35 – 12:30

Session XXII: New Options and Newer Approaches
Chairs: Necdet Uskent, Anes Pasic

11:35 - 11:55

  • New Treatment Option for Gastrointestinal Cancers: Trifluridine/Tipiracil Prolongs Survival in Advanced Gastric and Colon Cancer - Dilek Erdem

11:55 - 12:15

  • Pharmacogenetics for Colon Cancer - Ozge Keskin

12:15 - 12:30

  • Increasing Role of IMRT in GI Cancers - Cengiz Gemici
12:30 – 13:00 Session XXIII: Increasing Role of Biosimilars in Gastrointestinal Cancers
Chairs: Irfan Cicin, Arzu Yaren
Speaker: Christopher Twelves
13:00 - 13:10 Closing Remarks
Suayib Yalcin

 

5 December 2021, Sunday
ONLINE PROGRAM

 14:00 - 14:55

SELECTED ABSTRACTS PRESENTATION
Oral Presentation 1
Chairs: Sahin Lacin , Yusuf Karakas

OP-01
Prognostic Role of Pre-Operative Serum Ferritin Level in Stage 2 Colon Cancer
Hacer Demir

OP-02
Prediction of Acute Hematologic Toxicity Associated with Radiotherapy in Rectum Cancer with Artificial Intelligence
Deniz Kütri

OP-03
The Effect of Ras/Braf Mutational Status on Prognosis and Recurrence Pattern in Early Stage Colon Cancers
Nazlı Kunt

OP-04
The Relationship between the Thrombocyte/Lymphocyte Ratio, the Neutrophil/Lymphocyte Ratio and the Prognosis of Patients with Gastric Cancer Receiving Perioperative Chemotheraphy
Elif Sahin

OP-05
Comparison of Efficacy And Safety of 5-FU or Capecitabine, Combined with Cisplatin And Docetaxel (mDCF and mDCX) as First-Line Chemotherapy for Metastatic Gastric Cancer Patients: A Real-Life Study
Nail Paksoy

OP-06
Long-Term Survival Data in Gastric Cancer According to Stage in Turkey
Ahmet Siyar Ekinci

OP-07
Evaluation of the Impact of Preoperative Sarcopenia on Treatment Results and Survival in Patients with Pancreatic Cancer
Hakan Taban

OP-08
Prognostic Significance of Adipose Tissue Distribution and Metabolic Activity in PET / CT in Patients with Metastatic Colorectal Cancer
Mehmet Artac

OP-09
Advanced Hepatocellular Cancer in Turkey and Sorafenib Treatment: Real Life Experience
Cihan Erol

OP-10
Treatment Outcomes of Neoadjuvant Radiotherapy and Oxaliplatin-Based Chemotherapy in Patients with Rectal Cancer: Single-Center Experience
Ecem Yigit

OP-11
Retrospective Comparison of mFOLFIRINOX and Gemcitabine-Based Doublet Chemotherapy in Metastatic Pancreas Cancer as First-Line Treatment
Fatih Gurler

15:15 - 16:10

SELECTED ABSTRACTS PRESENTATION
Oral Presentation 2
Chairs: Ece Esin, Metin Demir

OP-12
Comparative Evaluation of Diagnostic Performances of GD-EOB MR and MDCT in Detecting Liver Metastases of Colorect Cancer
Levent Soydan

OP-13
Nuclear Exporter Protein Exportin 1 Inhibition Suppresses the Growth of Pancreatic Neuroendocrine Tumors
Asfar Sohail Azmi

OP-14
Clinical and Pathological Characteristics of Young Adult Colon Cancer Patients
Safa CAn Efil

OP-15
Evaluation of Gastrointestinal Cancer Patients Radiologically-Diagnosed with Sinusoidal Obstruction Syndrome: Single-Center Experience
Hakan Taban

OP-16
Oncological Outcomes of Stereotactic Body Radiation Therapy in Patients With Locally Advanced Pancreatic Cancer, Hacettepe University Experience
Alper Kahvecioglu

OP-17
Perioperative Predictors of Early Recurrence for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Retrospective Analysis of Single-Center Experience
Eda Caliskan Yildirim

OP-18
Realworld Treatment Outcomes from Nationwide Onco-Colon Turkey Registry in Patients with Metastatic Colorectal Cancer
Umut Kefeli

OP-20
Prognostic Factors Afecting the Patient Survival after Peptide Receptor Radionuclide Therapy: Does Change in ‘Somatostatin Receptor Positive Total Lesion’ has an Impact?
Bilge Volkan Salanci

OP-21
Relationship between Prognostic Nutritional Index and Neutrophil Lymphocyte Ratio with Overall Survival in Patients with Metastatic Colorectal Cancer Receiving Regorafenib
Mehmet Engin Ozekin

OP-22
Efficacy of Second-Line Chemotherapy in Metastatic Gastric Cancer; Retrospective Analysis
Yakup Duzkopru

16:30 - 18:25

SELECTED ABSTRACTS PRESENTATION
Oral Presentation 3
Chairs: Lutfiye Demir , Erkan Dogan

OP-23
A Rare Case with Secondary Hemochromatosis and Viral Hepatitis Associated with Blood Transfusions Due to Thalassemia
Batuhan Baspinar

OP-24
Hepatitis B Reactivation in Patients Receiving Chemotherapy and the Importance of Antiviral Prophylaxis
Mustafa Seyyar

OP-25
The Clinical and Pathological Features of Young Onset Colorectal Cancer Patients: a Single Center Experience
Mutlu Hizal

OP-26
Clınıcal Outcomes Of Pallıatıve 3-D Conformal External Beam Gastrıc Radıotherapy
Huseyin Furkan Ozturk

OP-27
Psoas Muscle Loss is a Negative Predictive Factor in Gastric Cancer Patients Treated with Chemoradiotherapy after Surgery
Huseyin Furkan Ozturk

OP-28
Log Odds of Positive Lymph Nodes Predicts the Survival in Resectable Pancreatic Adenocarcinoma
Anil Aysal

OP-29
Characteristic Features and Prognostic Factors in Gastric Cancer Patients with Bone Metastasis
Jamshid Hamdard

OP-30
The Importance of Yascular Invasion in Ampullary Carcinomas
Kadriye Ebru Akar

OP-31
Clinical and Pathological Characteristics of Proficient and Deficient Mismatch Repair Colon Cancers
Safa Can Efil

OP-32
Clinical and Pathological Characteristics of Resected Colon Cancer Patients with Early Relapse
Safa Can Efil

OP-33
Clinicopathological And Survival Features Of Neuroendocrine Tumors: A Retrospective Analysis Of 153 Cases
Seda Kahraman

OP-34
The Importance of Tumor Budding Evaluation in Ampullary Carcinomas
Kadriye Ebru Akar